Advanced Medical Optics (AMO) has received approval from the U.S....

Advanced Medical Optics (AMO) has received approval from the U.S. Food and Drug Administration (FDA) to market its CustomVue Monovision LASIK product, which is said to be the first LASIK device capable of treating one eye for myopia and the other eye for presbyopia.

Keep reading this article by becoming a member

barrier_image_OIC

Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.